Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Phagenesis Ltd.

Latest From Phagenesis Ltd.

Aimmune Gets $145m From Nestlé To Advance Food Allergy Immunotherapies

With the sizeable investment, Nestlé Health Sciences also gets a three-month right of first negotiation for licensing or partnering to develop any Aimmune candidates, including Phase III AR101 for peanut allergy.

Commercial Deals

M&A Deals Analysis: Big Bucks Are Back

September M&A deals picked up after a quiet summer with 23 M&A deals recorded, the busiest month of the year so far, which included two major deals closing at $4bn.

M & A Deals

New Products In Brief

InSightec, TriVascular and NicOx are among firms with notable recent product approvals or launches.

Medical Device

Start-Up Previews

This Month's Profile Group: Artificial Retinal Devices Help The Blind To See, features profiles of 2C Tech Corp., LambdaVision and Nano Retina. Plus these Start-Ups Across Health Care: Adenovir Pharma, Akrivis Technologies, Emboline and Phagenesis.

See All

Company Information

  • Industry
  • Medical Devices